z-logo
open-access-imgOpen Access
Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit
Author(s) -
Ulyana A. Mаrkina,
Daria S. Fomina,
Marina S. Lebedkina,
Tatiana S. Kruglova,
Anton A. Chernov,
Alena I. Zagrebneva,
Zinaida Yu. Mutovina,
Alexander Karaulov,
Е.I. Alexeeva,
М. А. Лысенко
Publication year - 2022
Publication title -
terapevtičeskij arhiv
Language(s) - English
Resource type - Journals
eISSN - 2309-5342
pISSN - 0040-3660
DOI - 10.26442/00403660.2022.05.201690
Subject(s) - medicine , retrospective cohort study , disease , observational study , adverse effect , covid-19 , single center , pediatrics , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here